(tetrazol-5-yl)glycine has been researched along with Seizures in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duncan, GE; Farrington, JS; Inada, K; Koller, BH | 1 |
Leander, JD; Lodge, D; Lunn, WH; Millar, JD; Sacaan, AI; Schoepp, DD; Smith, CL | 1 |
2 other study(ies) available for (tetrazol-5-yl)glycine and Seizures
Article | Year |
---|---|
Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction.
Topics: Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; Excitatory Amino Acid Agonists; Female; Genetic Predisposition to Disease; Glutamic Acid; Glycine; Hypothalamus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Proto-Oncogene Proteins c-fos; Receptors, N-Methyl-D-Aspartate; Seizures; Septal Nuclei; Solitary Nucleus; Synaptic Transmission; Tetrazoles | 2008 |
D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist.
Topics: Animals; Binding, Competitive; Cerebral Cortex; Glutamates; Glutamic Acid; Glycine; Kinetics; Male; Pipecolic Acids; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Seizures; Tetrazoles; Tritium | 1991 |